Copyright: ©Author(s) 2026.
World J Psychiatry. Aug 19, 2026; 16(8): 120278
Published online Aug 19, 2026. doi: 10.5498/wjp.120278
Published online Aug 19, 2026. doi: 10.5498/wjp.120278
Table 3 Receiver operating characteristic curve of variable sensitivity vs specificity
| Variable | AUC | 95%CI | P value | Youden index | Sensitivity | Specificity | PPV | NPV |
| NGF0 | 0.830 | 0.728-0.906 | < 0.001 | 0.647 | 89.66 | 75.00 | 91.2 | 71.4 |
| NGF1 | 0.842 | 0.742-0.915 | < 0.001 | 0.647 | 89.66 | 75.00 | 91.2 | 71.4 |
| NGF1 - NGF0 | 0.800 | 0.694-0.882 | < 0.001 | 0.557 | 70.69 | 85.00 | 93.2 | 50.0 |
| Early improvement | 0.674 | 0.559-0.776 | 0.021 | 0.348 | 44.83 | 90.00 | 92.9 | 36.0 |
| Combined variables | 0.925 | 0.843-0.972 | < 0.001 | 0.716 | 96.55 | 75.00 | 92.8 | 88.2 |
- Citation: Xiao WH, Wang ML, Chen KY, Yu DD, Zhao YQ, Sun JR. Assessment of nerve growth factor levels and clinical indicators for outcome prediction in first-episode schizophrenia. World J Psychiatry 2026; 16(8): 120278
- URL: https://www.wjgnet.com/2220-3206/full/v16/i8/120278.htm
- DOI: https://dx.doi.org/10.5498/wjp.120278